NCT02528786View on ClinicalTrials.gov

Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 19, 2015

Primary Completion Date

April 5, 2016

Study Completion Date

April 5, 2016

Conditions
Rheumatoid Arthritis
Interventions
OTHER

No Intervention

No study drug will be administered in this study.

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02528786 - Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study | Biotech Hunter | Biotech Hunter